Connection
Nathan Rabinovitch to Leukotriene Antagonists
This is a "connection" page, showing publications Nathan Rabinovitch has written about Leukotriene Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.952 |
|
|
|
-
Rabinovitch N, Mauger DT, Reisdorph N, Covar R, Malka J, Lemanske RF, Morgan WJ, Guilbert TW, Zeiger RS, Bacharier LB, Szefler SJ. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma. J Allergy Clin Immunol. 2014 Feb; 133(2):350-6.
Score: 0.444
-
Rabinovitch N, Graber NJ, Chinchilli VM, Sorkness CA, Zeiger RS, Strunk RC, Bacharier LB, Martinez FD, Szefler SJ. Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma. J Allergy Clin Immunol. 2010 Sep; 126(3):545-51.e1-4.
Score: 0.359
-
Rabinovitch N, Strand M, Stuhlman K, Gelfand EW. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. J Allergy Clin Immunol. 2008 Jun; 121(6):1365-71.
Score: 0.076
-
Rabinovitch N. Urinary leukotriene E4. Immunol Allergy Clin North Am. 2007 Nov; 27(4):651-64; vii.
Score: 0.074